Skip to content

Investigation of the Effects of Heavy Drinking Habits via Genetic Analysis of Self-Collected Samples

Investigation of the Effects of Heavy Drinking Habits via Genetic Analysis of Self-Collected Samples (Cross-Sectional Study) - Investigation of the Effects of Heavy Drinking Habits via Genetic Analysis of Self-Collected Samples (Cross-Sectional Study)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000058891
Enrollment
10
Registered
2025-11-10
Start date
2025-11-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heavy Drinking Habits -induced cognitive decline

Interventions

None listed

Sponsors

IMEQRD Co. Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Japanese men and women in their 20s at the time of written consent 2. AUDIT score of 15 or higher, or non-drinkers with an AUDIT score of 0 3. Received sufficient explanation of the study's purpose and content, demonstrated capacity to consent, voluntarily agreed to participate, and provided written consent

Exclusion criteria

Exclusion criteria: 1. Currently receiving medication or outpatient treatment for any serious illness (as-needed medication permitted) 2. Currently receiving treatment for, or with a history of, psychiatric disorders (e.g., depression) or sleep disorders 3. Blood donation of more than 200 mL within 1 month or more than 400 mL within 3 months prior to consent 4. History of feeling unwell or experiencing vasovagal reflex during blood collection 5. Difficulty in self-collecting nasal samples using a swab 6. Difficulty complying with survey questionnaire requirements 7. Currently participating in another clinical trial or planning to do so during the study period 8. Deemed unsuitable as a participant by the principal investigator for any other reason

Design outcomes

Primary

MeasureTime frame
Gene expression levels

Secondary

MeasureTime frame
-Blood biochemical tests -AUDIT -Smoking history -Exercise habits -Anxiety and depression symptoms (K6) -Sleep status (PSQI) -Correlation between primary and secondary outcomes

Countries

Japan

Contacts

Public ContactYoshitada Hira

IMEQRD Co., Ltd. Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026